StreetAlpha.app
Home › Stocks › IVA

Inventiva S.A. (IVA)

Healthcare
$3.14
▼ −8.99%
LAST CLOSE · NOV 20

Inventiva is a French biopharmaceutical company developing lanifibranor, an oral treatment for the liver disease MASH. It last closed at $3.14 on Nov 20, down 8.99% on the day.

AI Auto Pilots
Is IVA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IVA.

Key Stats

Last 12 months
Results
Revenue
EUR 13.6M
−12.8% vs a year ago
Net income
−EUR 311.1M
−2285.4% margin
Operating margin
−795.3%
−EUR 108.2M operating income
Balance sheet
Cash & equivalents
EUR 122.1M
At Jun 30
Shareholder equity
−EUR 8.9M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2020: EUR 372KEUR 372KFY2020FY2021: EUR 4.2MEUR 4.2MFY2021FY2022: EUR 12.2MEUR 12.2MFY2022FY2023: EUR 17.5MEUR 17.5MFY2023FY2024: EUR 9.2MEUR 9.2MFY2024

From IVA's SEC filings, latest 20-F for the period ending Jun 30, 2025 (filed Apr 8). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Ratings from the last 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on IVA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on IVA

Technical Analysis

IVA · as of the Nov 20 close · updated each morning
Downtrend

The stock is 17% below its 20 day and 12% below its 50 day average. It is 49% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39). The nearest support is the swing low (Sep 24) at $3.10, and the nearest resistance the Pivot at $3.24.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 9.0%/day
Key levels
$7.2952 week high+132.2%
$4.67200 day average+48.7%
$4.04100 day average+28.7%
$3.72Swing high (Jun 23)+18.5%
$3.6720 day average+16.9%
$3.5250 day average+12.1%
$3.34Pivot R1+6.4%
$3.24Pivot+3.2%
$3.14Last close
$3.10Swing low (Sep 24)−1.3%
$3.03Pivot S1−3.5%
$2.8252 week low−10.2%
Indicators
RSI (14)38.65Weak, oversold below 30Neutral
MACD-0.07Below its signal lineBearish
Stochastic19.0Near the bottom of its rangeOversold
ADX (14)23.1Weak trend
Williams %R-97.0Oversold below −80, overbought above −20Oversold
CCI (20)-174.6Oversold below −100, overbought above 100Oversold
Rate of change−17.4%Change over 10 sessionsBearish
ATR (14)$0.28Typical daily range, 9.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IVA

What happened before

See how IVA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow IVA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How IVA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for IVAHow many large options trades hit IVA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

IVA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲53 buying vs 38 selling
  • ▲Shares held by funds +7.9%
  • ▲Funds holding +10
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding9888+11.4%
In funds' top 10440.0%
Held by funds–––
New / increased25 / 2831 / 36−20.9%
Reduced / sold out23 / 157 / 7+171.4%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See IVA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IVA is in one of them and how their past IVA trades turned out.

IVA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered IVA in an article yet. Here's the latest on the wider market.

About Inventiva S.A.

Inventiva is a biopharmaceutical company based in Daix, France. It focuses on developing treatments for MASH, a progressive chronic liver disease marked by fat buildup, inflammation and scarring in the liver. Its main candidate, lanifibranor, is an orally available small molecule that is being studied in patients with MASH. The company aims to offer the treatment to these patients if regulators approve it.

Headquarters
Daix, France